---
layout: archive
title: "学术论文"
permalink: /publications/
author_profile: true
---
**#**Co-first author   *Co-corresponding author  

按照发表时间由近到远排序

1. Wang, W#., Yun, B#., Hoyle, R. G#., Ma, Z., Zaman, S. U., Xiong, G., Yi, C., Xie, N., Zhang, M., Liu, X., Bandyopadhyay, D., Li, J*., & **Wang C**. (2023). CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma. *Adv Sci (Weinh)*. Published online November 30, 2023. doi:10.1002/advs.202305002
2. Xie, J#., Zhang, J#., Xiong, G., Ouyang, S., Yun, B., Xu, X., Wang, W., Zhang, M., Xie, N., Chen, D., & **Wang, C**. (2023). Targeting BRD4 attenuates the stemness and aggressiveness of ameloblastoma. *Oral diseases*, 10.1111/odi.14762. Advance online publication. doi:10.1111/odi.14762
3. Xu X#, Xie J#, Ling R, Ouyang S, Xiong G, Lu Y, Yun B, Zhang M, Wang W, Liu X, Chen D, **Wang C***. Single-cell transcriptomic analysis uncovers the origin and intratumoral heterogeneity of parotid pleomorphic adenoma. Int J Oral Sci. 2023 Sep 7;15(1):38. doi: 10.1038/s41368-023-00243-2
4. Huang Z#, Lu Y#, Wang W#, Xie N, Yi C, Xiong G, Xu X, Zhang M, **Wang C***. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma. J Oral Pathol Med. 2023 May;52(5):372-380. doi: 10.1111/jop.13357.
5. Zhang X, Yi C, Zhang L, Zhu X, He Y, Lu H, Li Y, Tang Y, Zhao W, Chen G, **Wang C*** Huang S*, Ouyang G, Yu D\*. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy. Acta Biomater. 2023 Mar 15;159:338-352. doi: 10.1016/j.actbio.2023.01.023.
6. Xiong G#, Ouyang S#, Xie N, Xie J, Wang W, Yi C, Zhang M, Xu X, Chen D, **Wang C\***. FOSL1 promotes tumor growth and invasion in ameloblastoma. Front Oncol. 2022 Sep 15;12:900108. doi: 10.3389/fonc.2022.900108.
7. Zhang M#, Wang G#, Ma Z, Xiong G, Wang W, Huang Z, Wan Y, Xu X, Hoyle RG, Yi C, Hou J, Liu X, Chen D, Li J*, **Wang C\***. BET Inhibition Triggers Anti-tumor Immunity by Enhancing MHC Class I Expression in Head and Neck Squamous Cell Carcinoma. Mol Ther. 2022 Aug 2;S1525-0016(22)00443-9. doi: 10.1016/j.ymthe.2022.07.022.
8. Wang W#, Xie N#, Yi C, Zhang M, Xiong G, Xu X, Hou J, **Wang C\***. Prognostic and clinicopathological significance of cytocapsular tubes in oral squamous cell carcinoma. J Oral Pathol Med. 2022 Jul;51(6):520-528. doi: 10.1111/jop.13323. Epub 2022 Jun 30
9. Xu X#, Gan X#, Zhang M, Xie J, Chen S, Li K, Li J, Bao Y, **Wang C\*,** Chen D*. Sox9 + cells are required for salivary gland regeneration after radiation damage via the Wnt/β-catenin pathway. J Genet Genomics. 2022 Mar;49(3):230-239. doi: 10.1016/j.jgg.2021.09.008. Epub 2021 Oct 28.
10. **Wang C**, Li Y, Jia L, Kim JK, Li J, Deng P, Zhang W, Krebsbach PH, Wang CY*. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021 Sep 2;28(9):1597-1613.e7. doi: 10.1016/j.stem.2021.04.011. Epub 2021 May 3
11. **Wang C\***, Huang Z, Zhang M, Xiong G, Chen X, Xie N*. Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma. J Oral Pathol Med. 2021 Sep;50(8):776-784. doi: 10.1111/jop.13215. Epub 2021 Jun 29.
12. Wan Y#, Hoyle RG#, Xie N, Wang W, Cai H, Zhang M, Ma Z, Xiong G, Xu X, Huang Z, Liu X, Li J*, **Wang C\***. A Super-Enhancer Driven by FOSL1 Controls miR-21-5p Expression in Head and Neck Squamous Cell Carcinoma. Front Oncol. 2021 Apr 16;11:656628. doi: 10.3389/fonc.2021.656628. eCollection 2021
13. Feng K, Hu J, Huang Q, Cai W, Zhuang Z, Liu H, Hou J, Liu X, **Wang C***. Risk factors and Nomogram for Predicting Carotid Blowout Syndrome Based on Computed Tomography Angiography. Oral Dis. 2021 Mar 26. doi: 10.1111/odi.13859.
14. Zhang M#, Hoyle RG#, Ma Z, Sun B, Cai W, Cai H, Xie N, Zhang Y, Hou J, Liu X, Chen D, Kellogg GE, Harada H, Sun Y, **Wang C***, Li J*. FOSL1 Promotes Metastasis of Head and Neck Squamous Cell Carcinoma Through Super-Enhancer-Driven Transcription Program. Mol Ther. 2021 Aug 4;29(8):2583-2600. doi: 10.1016/j.ymthe.2021.03.024. 
15. Wang F#, Liao Y#, Zhang M#, Zhu Y, Wang W, Cai H, Liang J, Song F, Hou C, Huang S, Zhang Y, **Wang C***, Hou J*. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma. Oncogene. 2021 Jun;40(22):3885-3898. doi: 10.1038/s41388-021-01820-7. 
16. Wang F#, Zhu Y#, Cai H#, Liang J, Wang W, Liao Y, Zhang Y, **Wang C\***, Hou J*. N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma. Front Oncol. 2021 Nov 24;11:738406. doi: 10.3389/fonc.2021.738406.

17. Wang X#, Li K#, Wan Y#, Chen F, Cheng M, Xiong G, Wang G, Chen S, Chen Z, Chen J, Xu X, **Wang C***, Peng L*, Chen D*. Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma. Int J Oral Sci. 2021 Aug 11;13(1):26. doi: 10.1038/s41368-021-00130-8.
18. Zhuang Z#, Yu P#, Xie N#, Wu Y, Liu H, Zhang M, Tao Y, Wang W, Yin H, Zou B, Hou J, Liu X, Li J*, Huang H*, **Wang C\***. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma. Theranostics 2020; 10(3):1433-1453. doi:10.7150/thno.38507 
19. Wan Y, Liu H, Zhang M, Huang Z, Zhou H, Zhu Y, Tao Y, Xie N, Liu X, Hou J, **Wang C\*.** Prognostic Value of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Head Neck. 2020 May;42(5):1067-1076. doi: 10.1002/hed.26104. Epub 2020 Feb 12. 
20. Huang Z, Xie N, Liu H, Wan Y, Zhu Y, Zhang M, Tao Y, Zhou H, Liu X, Hou J, **Wang C***. The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis. J Oral Pathol Med. 2019 Oct;48(9):788-798
21. Xie N, Yu P, Liu H, Liu X, Hou J, Chen X, Huang H, **Wang C\***. Validation of the International Tumor Budding Consensus Conference (ITBCC 2016) Recommendations in Oral Tongue Squamous Cell Carcinoma. J Oral Pathol Med,2019; 48 (6), 451-458. 
22. Zhu Y, Liu H, Xie N, Liu X, Huang H, **Wang C***, Hou J*. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis. Head Neck. 2019 Feb;41(2):542-550.

23. Chen G, Liu H, Zhang Y, Liang J, Zhu Y, Zhang M, Yu D, **Wang C\***, Hou J*. Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma. Exp Cell Res. 2018 Sep 1;370(1):46-57.
24. Chen G, Zhang Y, Liang J, Li W, Zhu Y, Zhang M, **Wang C***, Hou J*. Deregulation of Hexokinase II Is Associated with Glycolysis, Autophagy, and the Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma under Hypoxia. Biomed Res Int. 2018 Feb 21;2018:8480762.
25. Xie N#, **Wang C#**, Zhuang Z, Hou J, Liu X, Wu Y, Liu H, Huang H. Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma. Oncotarget. Oncotarget. 2016, Oct 4;7(40):65744-65757. 
26. **Wang C**, Liu XQ, Hou JS, Wang JN, Huang HZ. Molecular Mechanisms of Chemoresistance in Oral Cancer. Chin J Dent Res. 2016 Mar;19(1):25-33.. 
27. Xie N#, **Wang C#,** Liu X, Li R, Hou J, Chen X, Huang H. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral Pathol Med. 2015 Apr;44(4):266-72. 
28. Weng J#, **Wang C#**, Wang Y, Tang H, Liang J, Liu X, Huang H, Hou J. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines. Oral Oncol. 2014 Oct;50(10):983-90. 
29. Wang Y#, **Wang C#**, Tang H, Tang H, Wang M, Weng J, Liu X, Zhang R, Huang H, Hou J. Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma. J Oral Pathol Med. 2013 Aug;42(7):557-64. 
30. **Wang C**, Liu X, Chen Z, Huang H, Jin Y, Kolokythas A, Wang A, Dai Y, Wong DT, Zhou X. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol Carcinog. 2013 Mar;52(3):229-36. 
31. **Wang C**, Liu X, Huang HZ, Ma HB, Cai WX, Hou JS, Huang L, Dai Y, Yu TW, Zhou XF. Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squmous cell carcinoma. Int J Cancer. 2012 May 15;130(10):2249-58. doi: 10.1002/ijc.26226. Epub 2011 Aug 16. 
32. **Wang C**, Huang HZ, Huang ZQ, Wang AX, Chen XH, Huang Lei, Zhou X, Liu XQ. Tumor budding correlates with poor prognosis and epithelial- mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med. 2011 Aug;40(7):545-51. 
33. Jin Y#, **Wang C#,** Liu X, Mu W, Chen Z, Yu D, Wang A, Dai Y, Zhou X. Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem. 2011 Nov 18;286(46):40104-9. Epub 2011 Oct 3. 
34. Liu X#, **Wang C#**, Chen Z, Jin Y, Wang Y, Kolokythas A, Dai Y, Zhou X. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem J. 2011 Nov 15;440(1):23-31. 
35. **Wang C,** Zeng RS, Wang JN, Huang HZ, Liu X, Wang A. Simultaneous maxillomandibular distraction osteogenesis in severe progressive hemifacial atrophy with two distractors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011,Mar;111(3):292-7. 
36. **Wang C,** Zeng RS, Wang JN, Huang HZ, Sun J, Luo ZB. The study of distraction osteogenesis with nitinol shape memory alloy controlled by infrared light. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010, Aug;110(2):157-66. 
37. Liu H, **Wang C**, Xie N, Zhuang Z, Liu X, Hou J, Huang H. Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma. Int J Mol Med. 2018 Jan;41(1):147-154.
38. Wang JN, **Wang C.** Osteofascial Compartment Syndrome: A Rare and Severe Complication Involved in Free Fibula Osteocutaneous Flaps and a Kind of Its Treatments. J Craniofac Surg. 2011 May;22(3):1100-2.
39. Cai H, Zhu Y, **Wang C**, Zhang Y, Hou J. Neck nodal recurrence and survival of clinical T1-2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: A meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Apr;129(4):296-310.
40. Weng J, Zhang H, **Wang C**, Liang J, Chen G, Li W, Tang H, Hou J. miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/β-Catenin Pathway in Tongue Squamous Cell Carcinoma. Biomed Res Int. 2017;2017:6010926.
41. Lü L, Liu X, **Wang C,** Hu F, Wang J, Huang H. Dissociation of E-cadherin/β-catenin complex by MG132 and bortezomib enhances CDDP induced cell death in oral cancer SCC-25 cells. Toxicol In Vitro. 2015 Dec;29(8):1965-76.
42. Wang J, Huang H, **Wang C**, Liu X, Hu F, Liu M. MicroRNA-375 sensitizes tumour necrosis factor-alpha (TNF-α)-induced apoptosis in head and neck squamous cell carcinoma in vitro. Int J Oral Maxillofac Surg. 2013 Aug;42(8):949-55
43. Chen Z, Liu X, **Wang C**, Jin Y, Wang Y, Wang A, Zhou X. p53 regulates the expression of human angiotensin II AT(2) receptor interacting protein (ATIP1) gene. Oncol Lett. 2011 Sep;2(5):919-922.
44. Chen D, Zhang W, Jia L, **Wang C**, Wang CY. Generation of a squamous cell carcinoma mouse model for lineage tracing of BMI1+ cancer stem cells. STAR Protoc. 2021 Apr 18;2(2):100484. doi: 10.1016/j.xpro.2021.100484.
45. Zhuang Z, Huang J, Wang W, **Wang C**, Yu P, Hu J, Liu H, Yin H, Hou J, Liu X. Down-Regulation of Long Non-Coding RNA TINCR Induces Cell Dedifferentiation and Predicts Progression in Oral Squamous Cell Carcinoma. Front Oncol. 2021 Feb 25;10:624752.
46. Zhuang Z, Huang J, Wang W, **Wang C**, Yu P, Hu J, Liu H, Yin H, Hou J, Liu X. Down-Regulation of Long Non-Coding RNA TINCR Induces Cell Dedifferentiation and Predicts Progression in Oral Squamous Cell Carcinoma. Front Oncol. 2021 Feb 25;10:624752.
47. Hu F, Chen X, Liu X, **Wang C,** Lv L, Xie N, Wang T, Huang H. Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma. Oncol Lett. 2015 Sep;10(3):1303-1308.
48. Jiang L, Dai Y, Liu X, **Wang C**, Wang A, Chen Z, Heidbreder CE, Kolokythas A, Zhou X. Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Hum Genet. 2011, Feb;129(2):189-97.
49. Liu X, Huang H, Wang J, **Wang C,** Wang M, Zhang B, Pan C. Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo. Biochem Pharmacol. 2011 Jul 1;82(1):17-23.
50. Zhang B, Liu M, Tang HK, Ma HB, **Wang C**, Chen X, Huang HZ. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. J Oral Pathol Med. 2012 Feb;41(2):141-8. doi: 10.1111/j.1600-0714.2011.01066.x. Epub 2011 Jul 28.
51. Zhuang Z, Xie N, Hu J, Yu P, **Wang C**, Hu X, Han X, Hou J, Huang H, Liu X. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma. Oncotarget. 2017 Mar 28;8(13):21954-21973.
52. Yu P, Wang W, Zhuang Z, Xie N, Xu J, **Wang C**, Hou J, Han X, Liu X. A novel prognostic model for tongue squamous cell carcinoma based on the characteristics of tumour and its microenvironment: iBD score. Histopathology. 2019 Apr;74(5):766-779. doi: 10.1111/his.13790. Epub 2019 Feb 13.
53. Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, **Wang C**, Liu X, Zhou X. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol. 2012 Aug;48(8):686-91.
54. Hou JS, Chen M, Pan CB, Tao Q, Wang JG, **Wang C**, Zhang B, Huang HZ. Immediate Reconstruction of Bilateral Mandible Defects: Management Based on Computer-Aided Design/Computer-Aided Manufacturing Rapid Prototyping Technology in Combination with Vascularized Fibular Osteomyocutaneous Flap. J Oral Maxillofac Surg. 2011 Jun;69(6):1792-7.
55. Hou JS, Chen M, Pan CB, Wang M, Wang JG, Zhang B, Tao Q, **Wang C**, Huang HZ. Application of CAD/CAM-assisted technique with surgical treatment in reconstruction of the mandible. J Craniomaxillofac Surg. 2012 Dec;40(8):e432-7.
56. He Y, Ma C, Hou J, Li X, Peng X, Wang H, Wang S, Liu L, Liu B, Tian L, Liu Z, Liu X, Xu X, Zhang D, Jiang C, Wang J, Yao Y, Zhu G, Bai Y, Wang S, Sun C, Li J, He S, **Wang C**, Zhang Z, Qiu W. Chinese expert group consensus on diagnosis and clinical management of osteoradionecrosis of the mandible. Int J Oral Maxillofac Surg. 2019 Jul 26. pii: S0901-5027(19)31191-9. doi: 10.1016/j.ijom.2019.06.015.
57. Zhu Y, Liang J, Wang F, Li J, **Wang C**, Hou J. Bacterial spectrum analysis and antimicrobial susceptibility study of osteoradionecrosis of the jaw in Southern China. Oral Dis. 2021 Jul 17. doi: 10.1111/odi.13968.
58. Wang X, Li K, Wan Y, Chen F, Cheng M, Xiong G, Wang G, Chen S, Chen Z, Chen J, Xu X, **Wang C**, Peng L, Chen D. Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma. Int J Oral Sci. 2021 Aug 11;13(1):26.
59. Cai H, Li J, Zhang Y, Liao Y, Zhu Y, **Wang C**, Hou J. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition. Front Oncol. 2019 Dec 19;9:1446.
60. Wang G, Zhang M, Cheng M, Wang X, Li K, Chen J, Chen Z, Chen S, Chen J, Xiong G, Xu X, **Wang C**, Chen D. Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms. Cancer Lett. 2021 Mar 17;507:55-69.
61. 黄洪章, **王成**. 大数据时代口腔癌精准诊疗的思考. 口腔疾病防, 2017, 25(5): 273–281.
62. 何悦; 侯劲松; 李晓光; 马春跃; 彭歆; 王慧明; 王松灵; 刘磊; 刘冰; 田磊; 刘忠龙; 刘习强; 徐昕; 张东升; 蒋灿华; 王军; 姚原; 朱国培; 白永瑞; 王胜资, 孙长伏, 李劲松, 何三纲, **王成**, Nabil Samman, 孙坚, 张陈平, 张志愿, 邱蔚六. 下颌骨放射性骨坏死临床诊疗专家共识.中国口腔颌面外科杂志, 2017, 15(5):445-456.
63. 张辉，**王成**，翁军权，张雯雯，杨冬叶，侯劲松（通讯作者）. 放射性颌骨坏死局部病灶菌群分析及药物敏感性研究［J/CD］. 中华口腔医学研究杂志：电子版，2016，10（3）：198⁃201.
64. 周沛玲，**王成**，梁建锋，罗罡，陈冠辉，李文清，侯劲松（通讯作者）. Beclin1和LC3在口腔鳞状细胞癌“瘤芽”中的表达及其与颈淋巴转移的关.. 中华口腔医学研究杂志：电子版，2016，10（4）：255⁃261.
65. 蔡伟鑫，**王成**, 马辉彬, 侯劲松, 刘习强, 陈小华, 黄洪章. 5-Aza对CDH1启动子甲基化及舌鳞状细胞癌细胞迁移能力的影响. 中华口腔医学研究杂志：电子版，2016，10（3）：155-160.
66. 马辉彬, **王成**, 蔡伟鑫, 侯劲松, 刘习强, 陈小华, 黄洪章. 乙醇诱导舌鳞状细胞癌上皮细胞间质转化. 中华口腔医学研究杂志：电子版，2016，10（6）：365-371. 
67. 吴越; **王成**; 谢楠; 庄泽航; 刘习强; 侯劲松; 黄洪章. miR-214在口腔鳞状细胞癌中的表达及功能研究. 中国口腔颌面外科杂志, 2016, 14(2):97-105.
68. 陈冠辉, **王成**, 翁军权, 梁建锋, 李文清, 竺越, 侯劲松. 低氧增强自噬促进舌鳞状细胞癌细胞迁移和侵袭. 2016，10（6）: 372-376
69. 宾志文，**王** **成**，吴晓林，侯劲松（通讯作者）. 两种骨肌皮瓣修复放射性下颌骨坏死术后缺损的临床评价，实用口腔医学杂志，2015，31（31）：408-412.
70. 梁建锋，**王** **成**，翁军权，陈冠辉，侯劲松（通讯作者）. 微小RNA-30a靶向Beclin1抑制舌鳞状细胞癌细胞自噬活性的研究，中华口腔医学研究杂志（电子版），2015，9（2）：5-8.
71. 陈小华, **王成**, 刘习强, 侯劲松, 潘朝斌, 王建广, 周晓峰, 黄洪章. 舌鳞癌中“瘤芽”的病理学特征及其与上皮-间质转化之间的关系.中国口腔颌面外科杂志,  2012,10(5):359-366. 
72. **王成**，黄洪章. 肿瘤进展过程中上皮间质变的研究进展. 国际肿瘤学杂志， 2009，36（8）：577-579.
73. **王成**，曾融生. 细胞凋亡在牵张成骨中的研究进展。国际口腔医学杂志，2008 35S:14-17.
74. **王成**，曾融生. 低强度脉冲超声在颌骨牵张成骨中的应用，国际口腔医学杂志，2007，34（5）：374-377.
75. 黄洪章，**王成**. 口腔癌侵袭转移的分子机制研究进展. 口腔颌面外科杂志，2010, 20(2):77-82
76. 曾融生，**王成**，朱双林，王剑宁. 上下颌同步牵张成骨治疗半侧颜面萎缩畸形，中华口腔医学研究杂志, 2008, 2 (2): 152-158.
77. 周婷, **王成**, 曾融生, 杨小平, 王剑宁, 刘习强, 王荣洁, 朱凯. 正颌外科手术前、后患者人格特征的变化.中国口腔颌面外科杂志，2012,10(5):377-380
78. 刘墨, 张斌, **王成**, 刘习强, 王剑宁, 黄洪章. 转化生长因子β1 诱导人舌鳞状细胞癌细胞上皮－间质转化及其顺铂耐药性研究. 中华口腔医学研究杂志（电子版），2012，6（3）:223-231.
79. 陈沐, 侯劲松, **王成**, 汪淼, 黄洪章.全反式维甲酸对C57小鼠胚胎腭突Bmpr-1b表达的影响. 中华口腔医学研究杂志（电子版），2012，6（6）:223-231.490-496.
80. 曾融生，张朋，**王成**. 镍钛记忆合金牵张成骨修复犬下颌骨缺损截骨方式的选择，中国组织工程研究与临床康复, 2008, 12 (2): 217-220.
81. 曾融生，杨小平，**王成**. 可吸收内固定系统在颅颌面外科中的应用. 中国口腔颌面外科杂志，2007, 5 (6): 402-407.
82. 张朋，曾融生，**王成**. HIF-1α 在犬下颌骨持续牵张成骨中的表达及与局部血管形成的关系. 中华口腔医学研究杂志（电子版），2008，2（5）：467-475.
83. 刘舒畅, 胡静, 侯劲松, **王成**, 刘习强, 黄洪章. 507例放射性颌骨坏死回顾性分析及临床新分期的建立：单一中心20年经验. 中华口腔医学研究杂志（电子版），2016，10（5）：337-342.
84. 侯劲松，汪淼，唐海阔，陶谦，潘朝斌，陈沐，**王成**，廖贵清，杨小平，黄洪章. 预成钛网联合自体髂骨及松质骨游离移植二期修复单侧下颌骨缺损. 中华口腔医学研究杂志（电子版）.2010,4(6):597-603.
85. 侯劲松, 廖贵清, 潘朝斌, 陶谦, 王建广, 张彬, 杨辛, **王成**, 陈沐, 黄洪章.CAD/CAM联合游离腓骨肌皮瓣修复双侧下颌骨大范围骨缺损. 中国口腔颌面外科杂志.2011, 9 (1):36-40.

 